You are here :
Published on: Jun 2022 | From USD $2900 | Published By: MAIA RESEARCH JAPANESE | Number Of Pages: 100
CrohnÂ’s disease refers to long term inflammatory bowel disease, which causes inflammation of the lining of the digestive tract. It affects the large and small intestine and is generally diagnosed in persons within the age group of 20-29. It can have severe or acute outcomes. Signs and symptoms of CrohnÂ’s disease develop slowly and gradually. Some of the common symptoms of this disease include abdominal pain and cramping, fever, fatigue, diarrhea, blood in stools, appetite and weight loss. Inflammation of skin, joints, and eyes, inflammation of the liver or bile duct, and delayed sexual development in children are some other symptoms associated with severe CrohnÂ’s disease.
Rising number of drug therapies for CrohnÂ’s disease and increasing demand for better diagnostics and treatment options for the auto-immune disease are some of the key factors driving the growth of the global CrohnÂ’s disease market. In addition, rise in the number of patients suffering from auto-immune disorders in developing countries and increasing government initiatives for improving health care infrastructure are fueling the growth of the global CrohnÂ’s disease market. However, less awareness among people about the disease is also restraining the growth of the market. Patent expiry of various useful drugs, such as remicade and humira, is also impeding the growth of the market.
Market Analysis and Insights: Global Crohn's Disease Market
The global Crohn's Disease market size is projected to reach US$ 11030 million by 2027, from US$ 8655.3 million in 2020, at a CAGR of 3.1% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Crohn's Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Crohn's Disease market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Crohn's Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Crohn's Disease market.
Global Crohn's Disease Scope and Market Size
Crohn's Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Crohn's Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Surgery
Drug Therapy
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbvie
Amgen
Cambridge Antibody Technology
Janssen Biotech
Pfizer
Tillotts Pharma
Johnson & Johnson
Boehringer Ingelheim
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Crohn's Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgery
1.2.3 Drug Therapy
1.3 Market by Application
1.3.1 Global Crohn's Disease Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Crohn's Disease Market Perspective (2016-2027)
2.2 Crohn's Disease Growth Trends by Regions
2.2.1 Crohn's Disease Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Crohn's Disease Historic Market Share by Regions (2016-2021)
2.2.3 Crohn's Disease Forecasted Market Size by Regions (2022-2027)
2.3 Crohn's Disease Industry Dynamic
2.3.1 Crohn's Disease Market Trends
2.3.2 Crohn's Disease Market Drivers
2.3.3 Crohn's Disease Market Challenges
2.3.4 Crohn's Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Crohn's Disease Players by Revenue
3.1.1 Global Top Crohn's Disease Players by Revenue (2016-2021)
3.1.2 Global Crohn's Disease Revenue Market Share by Players (2016-2021)
3.2 Global Crohn's Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Crohn's Disease Revenue
3.4 Global Crohn's Disease Market Concentration Ratio
3.4.1 Global Crohn's Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Crohn's Disease Revenue in 2020
3.5 Crohn's Disease Key Players Head office and Area Served
3.6 Key Players Crohn's Disease Product Solution and Service
3.7 Date of Enter into Crohn's Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Crohn's Disease Breakdown Data by Type
4.1 Global Crohn's Disease Historic Market Size by Type (2016-2021)
4.2 Global Crohn's Disease Forecasted Market Size by Type (2022-2027)
5 Crohn's Disease Breakdown Data by Application
5.1 Global Crohn's Disease Historic Market Size by Application (2016-2021)
5.2 Global Crohn's Disease Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Crohn's Disease Market Size (2016-2027)
6.2 North America Crohn's Disease Market Size by Type
6.2.1 North America Crohn's Disease Market Size by Type (2016-2021)
6.2.2 North America Crohn's Disease Market Size by Type (2022-2027)
6.2.3 North America Crohn's Disease Market Size by Type (2016-2027)
6.3 North America Crohn's Disease Market Size by Application
6.3.1 North America Crohn's Disease Market Size by Application (2016-2021)
6.3.2 North America Crohn's Disease Market Size by Application (2022-2027)
6.3.3 North America Crohn's Disease Market Size by Application (2016-2027)
6.4 North America Crohn's Disease Market Size by Country
6.4.1 North America Crohn's Disease Market Size by Country (2016-2021)
6.4.2 North America Crohn's Disease Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Crohn's Disease Market Size (2016-2027)
7.2 Europe Crohn's Disease Market Size by Type
7.2.1 Europe Crohn's Disease Market Size by Type (2016-2021)
7.2.2 Europe Crohn's Disease Market Size by Type (2022-2027)
7.2.3 Europe Crohn's Disease Market Size by Type (2016-2027)
7.3 Europe Crohn's Disease Market Size by Application
7.3.1 Europe Crohn's Disease Market Size by Application (2016-2021)
7.3.2 Europe Crohn's Disease Market Size by Application (2022-2027)
7.3.3 Europe Crohn's Disease Market Size by Application (2016-2027)
7.4 Europe Crohn's Disease Market Size by Country
7.4.1 Europe Crohn's Disease Market Size by Country (2016-2021)
7.4.2 Europe Crohn's Disease Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Crohn's Disease Market Size (2016-2027)
8.2 Asia-Pacific Crohn's Disease Market Size by Type
8.2.1 Asia-Pacific Crohn's Disease Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Crohn's Disease Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Crohn's Disease Market Size by Type (2016-2027)
8.3 Asia-Pacific Crohn's Disease Market Size by Application
8.3.1 Asia-Pacific Crohn's Disease Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Crohn's Disease Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Crohn's Disease Market Size by Application (2016-2027)
8.4 Asia-Pacific Crohn's Disease Market Size by Region
8.4.1 Asia-Pacific Crohn's Disease Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Crohn's Disease Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Crohn's Disease Market Size (2016-2027)
9.2 Latin America Crohn's Disease Market Size by Type
9.2.1 Latin America Crohn's Disease Market Size by Type (2016-2021)
9.2.2 Latin America Crohn's Disease Market Size by Type (2022-2027)
9.2.3 Latin America Crohn's Disease Market Size by Type (2016-2027)
9.3 Latin America Crohn's Disease Market Size by Application
9.3.1 Latin America Crohn's Disease Market Size by Application (2016-2021)
9.3.2 Latin America Crohn's Disease Market Size by Application (2022-2027)
9.3.3 Latin America Crohn's Disease Market Size by Application (2016-2027)
9.4 Latin America Crohn's Disease Market Size by Country
9.4.1 Latin America Crohn's Disease Market Size by Country (2016-2021)
9.4.2 Latin America Crohn's Disease Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Crohn's Disease Market Size (2016-2027)
10.2 Middle East & Africa Crohn's Disease Market Size by Type
10.2.1 Middle East & Africa Crohn's Disease Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Crohn's Disease Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Crohn's Disease Market Size by Type (2016-2027)
10.3 Middle East & Africa Crohn's Disease Market Size by Application
10.3.1 Middle East & Africa Crohn's Disease Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Crohn's Disease Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Crohn's Disease Market Size by Application (2016-2027)
10.4 Middle East & Africa Crohn's Disease Market Size by Country
10.4.1 Middle East & Africa Crohn's Disease Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Crohn's Disease Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Details
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Crohn's Disease Introduction
11.1.4 Abbvie Revenue in Crohn's Disease Business (2016-2021)
11.1.5 Abbvie Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Crohn's Disease Introduction
11.2.4 Amgen Revenue in Crohn's Disease Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 Cambridge Antibody Technology
11.3.1 Cambridge Antibody Technology Company Details
11.3.2 Cambridge Antibody Technology Business Overview
11.3.3 Cambridge Antibody Technology Crohn's Disease Introduction
11.3.4 Cambridge Antibody Technology Revenue in Crohn's Disease Business (2016-2021)
11.3.5 Cambridge Antibody Technology Recent Development
11.4 Janssen Biotech
11.4.1 Janssen Biotech Company Details
11.4.2 Janssen Biotech Business Overview
11.4.3 Janssen Biotech Crohn's Disease Introduction
11.4.4 Janssen Biotech Revenue in Crohn's Disease Business (2016-2021)
11.4.5 Janssen Biotech Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Crohn's Disease Introduction
11.5.4 Pfizer Revenue in Crohn's Disease Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Tillotts Pharma
11.6.1 Tillotts Pharma Company Details
11.6.2 Tillotts Pharma Business Overview
11.6.3 Tillotts Pharma Crohn's Disease Introduction
11.6.4 Tillotts Pharma Revenue in Crohn's Disease Business (2016-2021)
11.6.5 Tillotts Pharma Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Crohn's Disease Introduction
11.7.4 Johnson & Johnson Revenue in Crohn's Disease Business (2016-2021)
11.7.5 Johnson & Johnson Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Details
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Crohn's Disease Introduction
11.8.4 Boehringer Ingelheim Revenue in Crohn's Disease Business (2016-2021)
11.8.5 Boehringer Ingelheim Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.